Author

Shih Sheng Jiang

National Health Research InstitutesORCID 0000-0003-1909-437XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Chun‐Mei HuiD· 1 shared Chun‐Nan OuYang· 1 shared Hsuan-Chung Chen· 1 shared Kai-Ping Chang· 1 shared Ming‐Qing LiiD· 1 shared Ngan‐Ming TsangiD· 1 shared Shu‐Chen LiuiD· 1 shared Tzu-Tung LiuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chun‐Mei HuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 12, 2025

Targeting STING-ATM axis overcomes radiotherapy-induced immune suppression and restores anti-tumor immunity in nasopharyngeal carcinoma

Tzu-Tung Liu, Kai-Ping Chang, Yunong Wang…·Shu‐Chen Liu

This study shows that targeting the STING-ATM axis with a STING agonist overcomes radiotherapy-induced immune suppression in nasopharyngeal carcinoma, enhancing anti-tumor immunity and tumor control.

DOI 10.1101/2025.11.12.687945

mousescRNA-seq

𝕏 PostBluesky